Should I apply for Gujarat Kidney and Super Speciality Limited IPO?
Based on our analysis, our rating for Gujarat Kidney and Super Speciality Limited IPO is: Neutral. Review the full analysis including strengths, risks, and financials on CheckIPO before making a decision.
What are the key risks of Gujarat Kidney and Super Speciality Limited IPO?
The company has acquired several hospitals from promoters and may continue such related-party acquisitions. Acquisitions and integrations involve operational, financial, and regulatory risks. Rapid expansion across multiple hospitals increases management and operational complexity.
What are the strengths of Gujarat Kidney and Super Speciality Limited IPO?
Strong capabilities in renal sciences with established urology subspecialties. Strategically located, right-sized hospitals providing efficient capital returns. Proven ability to attract, train, and retain skilled medical professionals.
What is the price band of Gujarat Kidney and Super Speciality Limited IPO?
The price band for Gujarat Kidney and Super Speciality Limited IPO is 108-114. The IPO has closed.